The Botulinum Toxin Safety Use Committee under the Korea Risk Management Council announced the results of the '2024 Botulinum Toxin Consumer Survey' on the 27th. The committee conducted a consumer ...

As recognized with approvals from the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and Health Canada, Daewoong Pharmaceutical's botulinum toxin has demonstrated ...

Market DriversSeveral key factors are contributing to the rapid expansion of the botulinum toxin market: Growing Demand for ...

The Hugel-manufactured Letybo has soared in popularity in South Korea, where providers “have used it zillions of times,” Dr. Roy Kim, a board-certified plastic surgeon based in San Francisco, told ...

Botulinum toxin (BTX) has been used at Baylor’s Parkinson’s Disease Center and Movement Disorders Clinic (PDCMDC) in the treatment of dystonia and related disorders since 1983. Its safety and efficacy ...